Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Early Hum Dev ; 182: 105793, 2023 07.
Artigo em Inglês | MEDLINE | ID: mdl-37263155

RESUMO

AIM: Determine incidence of visual impairment due to retinopathy of prematurity (ROP) and concomitant disabilities between 2009 and 2018 in the Netherlands and compare data to four former similar studies. Secondly, monitor if infants were missed for ROP-screening since the adoption of stricter, risk factor guided criteria (2013). METHODS: Retrospective inventory on anonymous data of infants diagnosed with ROP from Dutch visual impairment-institutes. Data including: best corrected visual acuity, ROP-treatment and concomitant disabilities: bronchopulmonary dysplasia, behavioral abnormalities, epilepsy, hearing deficit, developmental delay, cerebral palsy and cerebral visual impairment. During the study period, lower age limit for neonatal life support (2010) and higher oxygen saturation targets (2014) were implemented. RESULTS: Records of 53 infants were analyzed. Visual impairment incidence due to ROP was 2.02 per 100.000 live births (2000-2009: 1.84, p = 0.643). Compared to earlier periods (1975-2000), a significant decrease was observed. The incidence of concomitant disabilities remained stable. Mean gestational age (GA) continued to decrease to 26.6 ± 1.9 weeks (2000-2009: 27.4 ± 2.0 weeks, p = 0.047). All patients met the screening inclusion criteria. CONCLUSION: The incidence of visual impairment due to ROP and concomitant disabilities between 2009 and 2018 has not increased, despite lower GA and higher oxygen saturation targets. None of the infants were missed for ROP screening following introduction of more restricted screening inclusion criteria.


Assuntos
Retinopatia da Prematuridade , Recém-Nascido , Lactente , Humanos , Retinopatia da Prematuridade/complicações , Retinopatia da Prematuridade/epidemiologia , Retinopatia da Prematuridade/diagnóstico , Países Baixos/epidemiologia , Estudos Retrospectivos , Peso ao Nascer , Idade Gestacional , Transtornos da Visão/epidemiologia , Transtornos da Visão/etiologia , Fatores de Risco , Triagem Neonatal , Incidência
3.
Acta Ophthalmol ; 90(2): 188-92, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20222904

RESUMO

PURPOSE: To evaluate the incidence of exposure keratopathy following silicone frontalis suspension in adult neuro- and myogenic blepharoptosis. METHOD: Retrospective noncomparative analysis of the charts of 69 cases (101 eyelids) of silicone frontalis suspension. RESULTS: Sixty-one patients (93 eyelids) had myogenic ptosis, and eight patients (eight eyelids) had neurogenic ptosis. Preoperative diagnoses included chronic progressive external ophthalmoplegia, myotonic dystrophy, oculopharyngeal dystrophy, third cranial nerve palsy because of trauma or other causes. Average age at the time of operation was 54. Mean interval between the intervention and the first and second postoperative control was 8 and 28 months, respectively. Thirty-one patients (31 eyelids) needed a second follow-up visit. Postoperative punctate epithelial erosions (PEE) were encountered most frequently in patients with Steinert's disease (42% of eyes) and congenital ptosis (33% of eyes). Patients with oculopharyngeal dystrophy did not develop PEE. Corneal ulceration developed in three eyes (two patients): one eye was successfully treated with local antibiotic ointments and lubricants, a bilateral corneal ulceration in the second patient was successfully treated with partial conjunctival grafts. CONCLUSION: This study cohort demonstrated a 26% risk of exposure keratopathy following silicone frontalis suspension. The risk of major corneal complications, such as ulceration, was low (3%).


Assuntos
Blefaroptose/cirurgia , Doenças da Córnea/etiologia , Implantação de Prótese/efeitos adversos , Elastômeros de Silicone , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Blefaroptose/etiologia , Túnica Conjuntiva/transplante , Doenças da Córnea/terapia , Remoção de Dispositivo , Feminino , Humanos , Incidência , Lubrificantes/administração & dosagem , Masculino , Pessoa de Meia-Idade , Doenças Musculares/complicações , Doenças do Sistema Nervoso/complicações , Músculos Oculomotores/cirurgia , Reoperação , Estudos Retrospectivos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA